title: The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi Arabia.
abstract: OBJECTIVE
  To assess the trend of using pharmacoeconomic information by Pharmacy and Therapeutics (P&T) committees when making formulary decisions.
  
  
  METHODS
  A cross-sectional study conducted in 2007, using structured survey questionnaires which were distributed to members of the P&T committees in 11 different hospitals in Riyadh, Saudi Arabia.
  
  
  RESULTS
  A total of 100 survey questionnaires were sent to head of pharmacy departments of 11 different hospitals in Riyadh, Saudi Arabia. Out of these, 48 questionnaires were completed and returned. Of the total respondents participated in the study, 64.58% were medical doctors and 16.66% were pharmacists and 75% of the respondents said they have applied pharmacoeconomic evaluations in their decision making process. More than 80% of the respondents perceived that they had a fair knowledge of pharmacoeconomics. Approximately 80% of respondents expressed some degree of agreement that pharmacoeconomics should be applied as a decision making tool. The majority of decision-makers (95%) expressed the interest in attending workshops on pharmacoeconomics.
  
  
  CONCLUSIONS
  The study showed that pharmacoeconomics can play an important role in the P&T committee formulary decisions. However, more education to health care professionals and to hospital administrators should be conducted to facilitate the use of such a tool. Also, hospitals should recruit health care professionals with pharmacoeconomic expertise to manage limited health resources in the best way available.
authors: Pharmacoeconomic and Outcomes Research Unit, Department of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2487, Riyadh 11451, Saudi Arabia.
authors: Mohammed S
authors: MS
authors: Alsultan
keywords: Formulary decision; Pharmacoeconomics; Pharmacy and Therapeutics committees; Saudi Arabia
references: Soc Sci Med. 2007 Nov;65(10):2116-29
references: 17698271
references: Clin Ther. 2003 Apr;25(4):1276-92
references: 12809973
references: Pharm World Sci. 2003 Dec;25(6):269-75
references: 14689815
references: Health Policy. 2009 Mar;89(3):261-70
references: 18657336
references: Expert Rev Pharmacoecon Outcomes Res. 2001 Oct;1(1):7-12
references: 19807502
references: Am J Hosp Pharm. 1989 Apr;46(4):714-9
references: 2719049
references: Pharmacoeconomics. 2002;20(1):9-21
references: 11817989
references: Health Policy. 2008 May;86(2-3):129-41
references: 18192059
references: Pharmacoeconomics. 1995 Sep;8(3):182-9
references: 10155616
references: Am J Health Syst Pharm. 2006 Sep 1;63(17):1613-8
references: 16914631
references: Am J Manag Care. 1999 Oct;5(10):1311-7; quiz 1318-9
references: 10622996
references: Health Policy. 2008 Dec;88(2-3):308-16
references: 18508151
references: Am J Hosp Pharm. 1992 Sep;49(9):2207-10
references: 1524063
references: Health Policy. 2008 Apr;86(1):1-9
references: 17950484
references: Clin Ther. 1993 Nov-Dec;15(6):1121-32; discussion 1120
references: 8111809
references: Soc Sci Med. 1997 Aug;45(4):511-21
references: 9226777
references: Am J Manag Care. 2002 Feb;8(2):161-9
references: 11858228
references: Am J Health Syst Pharm. 2002 Aug 1;59(15):1441-4
references: 12166044
references: Am J Health Syst Pharm. 2003 Jan 15;60(2):137-49
references: 12561658
references: Am J Health Syst Pharm. 1999 Mar 15;56(6):537-42
references: 10192688
references: J Eur Acad Dermatol Venereol. 2005 Sep;19 Suppl 1:34-9
references: 16120204